Literature DB >> 12749766

A splice variant acquiring an extra transcript leader region decreases the translation of glutamine synthetase gene.

Daesung Shin1, Sangjin Park, Chankyu Park.   

Abstract

The expression of glutamine synthetase (GS), catalysing the ATP-dependent conversion of glutamate and ammonia into glutamine, is transcriptionally and post-transcriptionally regulated. The genomic structure of dog GS shown in the present study is basically similar to that of other mammals in that it is composed of seven exons and six introns. Using 5'-cRACE (where cRACE stands for circular rapid amplification of cDNA ends) and reverse transcriptase-PCR, we identified an additional exon (120 bp) in the first intron, designated in the present study as exon 1'. By means of alternative splicing, the GS gene produces an altered form of GS transcript with 5'-untranslated region (UTR) containing the exon 1'. This alternative transcript is abundantly expressed in brain, whereas it is found at lower levels in other tissues. In the human and mouse GS genes, extra exons are also found at the corresponding site of the intron 1 but with different sizes. An exon-trapping experiment for the GS gene in COS-7, Madin-Darby canine kidney and SK-N-SH cells revealed that the pattern of alternative splicing is variable in different cell types. The propensity of forming a secondary structure is predicted to be considerably higher in the presence of extra 5'-UTR, suggesting the possibility of a translational effect. To test this, we performed a reporter assay for fusions with different 5'-UTRs, demonstrating that the long form with extra 5'-UTR was translated 20- and 10-fold less than the short one in SK-N-SH and Neuro-2A cells respectively. Similarly, translations of human and mouse transcripts with extra 5'-UTRs were less efficient, showing 6-8-fold reductions in SK-N-SH cells. Furthermore, when we mutated an ATG sequence contained in the exon 1', the suppression of translation was partially relieved, suggesting that the negative regulation by an extra 5'-UTR is, to some extent, due to an abortive translation from the upstream ATG.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12749766      PMCID: PMC1223576          DOI: 10.1042/BJ20030132

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

Review 1.  New ways of initiating translation in eukaryotes?

Authors:  M Kozak
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

2.  Presence of ATG triplets in 5' untranslated regions of eukaryotic cDNAs correlates with a 'weak' context of the start codon.

Authors:  I B Rogozin; A V Kochetov; F A Kondrashov; E V Koonin; L Milanesi
Journal:  Bioinformatics       Date:  2001-10       Impact factor: 6.937

3.  Regulated translation of heparan sulfate N-acetylglucosamine N-deacetylase/n-sulfotransferase isozymes by structured 5'-untranslated regions and internal ribosome entry sites.

Authors:  Kay Grobe; Jeffrey D Esko
Journal:  J Biol Chem       Date:  2002-06-17       Impact factor: 5.157

Review 4.  On finding all suboptimal foldings of an RNA molecule.

Authors:  M Zuker
Journal:  Science       Date:  1989-04-07       Impact factor: 47.728

5.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

Review 6.  An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs.

Authors:  M Kozak
Journal:  Nucleic Acids Res       Date:  1987-10-26       Impact factor: 16.971

7.  Glutamate metabolism in the frog retina.

Authors:  A J Kennedy; M J Voaden; J Marshall
Journal:  Nature       Date:  1974-11-01       Impact factor: 49.962

8.  Identification of a cis-acting element and a novel trans-acting factor of the glutamine synthetase gene in liver cells.

Authors:  F Gaunitz; S Weber; L Scheja; R Gebhardt
Journal:  Biochem Biophys Res Commun       Date:  2001-06-08       Impact factor: 3.575

9.  A proinsulin gene splice variant with increased translation efficiency is expressed in human pancreatic islets.

Authors:  Anath Shalev; Patrick J Blair; Steven C Hoffmann; Boaz Hirshberg; Brenda A Peculis; David M Harlan
Journal:  Endocrinology       Date:  2002-07       Impact factor: 4.736

10.  Dibutyryl cyclic AMP decreases glutamine synthetase in cultured 3T3-L1 adipocytes.

Authors:  R E Miller; D A Carrino
Journal:  J Biol Chem       Date:  1980-06-10       Impact factor: 5.157

View more
  5 in total

Review 1.  Inborn error of amino acid synthesis: human glutamine synthetase deficiency.

Authors:  Johannes Häberle; Boris Görg; Annick Toutain; Frank Rutsch; Jean-François Benoist; Antoinette Gelot; Annie-Laure Suc; Hans Georg Koch; Freimut Schliess; Dieter Häussinger
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

Review 2.  Critical Evaluation of the Changes in Glutamine Synthetase Activity in Models of Cerebral Stroke.

Authors:  Thomas M Jeitner; Kevin Battaile; Arthur J L Cooper
Journal:  Neurochem Res       Date:  2015-08-02       Impact factor: 3.996

3.  Forms of selenium in vitamin-mineral mixes differentially affect serum prolactin concentration and hepatic glutamine synthetase activity of steers grazing endophyte-infected tall fescue.

Authors:  Yang Jia; Qing Li; W R Burris; Glenn E Aiken; Phillip J Bridges; James C Matthews
Journal:  J Anim Sci       Date:  2018-03-06       Impact factor: 3.159

4.  Evolutionary conservation suggests a regulatory function of AUG triplets in 5'-UTRs of eukaryotic genes.

Authors:  Alexander Churbanov; Igor B Rogozin; Vladimir N Babenko; Hesham Ali; Eugene V Koonin
Journal:  Nucleic Acids Res       Date:  2005-09-26       Impact factor: 16.971

5.  Brainstem development requires galactosylceramidase and is critical for pathogenesis in a model of Krabbe disease.

Authors:  Nadav I Weinstock; Conlan Kreher; Jacob Favret; Duc Nguyen; Ernesto R Bongarzone; Lawrence Wrabetz; M Laura Feltri; Daesung Shin
Journal:  Nat Commun       Date:  2020-10-23       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.